-transparent.png){kind=logo}
An Indian (Asian) patient with compound heterozygosity for Hb Riyadh and beta 0-thalassemia is described. Hb Riyadh forms about 95% of the hemoglobin present. The clinico-pathological picture is identical to that of simple beta-thalassemia trait confirming the harmless nature of the substitution beta 120(GH3) Lys leads to Asn.
Related Publications
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
July 1989,
Israel journal of medical sciences,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
January 1988,
The American journal of pediatric hematology/oncology,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
January 1985,
Acta haematologica,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
October 2001,
European journal of haematology,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
January 1989,
Lijecnicki vjesnik,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
April 2005,
Saudi medical journal,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
November 1988,
JPMA. The Journal of the Pakistan Medical Association,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
March 1978,
Clinical genetics,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
March 1965,
American journal of human genetics,
P H Pinkerton, and
J B Wilson, and
H Lam, and
D Williams, and
T H Huisman
November 2009,
American journal of hematology,
